Discontinued — last reported Q4 '25
Financing
Share Buybacks
West Pharmaceutical Services Share Buybacks increased by 59420.0% to $297.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 122.9%, from $133.50M to $297.60M. Over 2 years (FY 2022 to FY 2024), Share Buybacks shows an upward trend with a 66.3% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ4 2025
How to read this metric
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
Detailed definition
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Peer comparison
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
Metric ID:
share_repurchasesHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $147.10M | $28.60M | $27.20M | $0.00 | $60.10M | $173.40M | $27.80M | $177.00M | $267.00M | $187.10M | $52.40M | $54.40M | $133.50M | $500.00K | $297.60M |
| QoQ Change | — | -80.6% | -4.9% | -100.0% | — | +188.5% | -84.0% | +536.7% | +50.8% | -29.9% | -72.0% | +3.8% | +145.4% | -99.6% | >999% |
| YoY Change | — | — | — | — | -59.1% | +506.3% | +2.2% | — | +344.3% | +7.9% | +88.5% | -69.3% | -50.0% | -99.7% | +122.9% |
Range$0.00 – $297.60M
CAGR+22.3%
Avg YoY Growth+79.4%
Median YoY Growth+5.1%
Share Buybacks at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's share buybacks?
- West Pharmaceutical Services (WST) reported share buybacks of $297.60M in Q1 2026.
- How has West Pharmaceutical Services's share buybacks changed year-over-year?
- West Pharmaceutical Services's share buybacks increased by 122.9% year-over-year, from $133.50M to $297.60M.
- What is the long-term trend for West Pharmaceutical Services's share buybacks?
- Over 2 years (2022 to 2024), West Pharmaceutical Services's share buybacks has grown at a 66.3% compound annual growth rate (CAGR), from $202.90M to $560.90M.
- What does share buybacks mean?
- Cash spent by the company to buy back its own stock.